Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-12-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2021.16.PO10 |
| _version_ | 1826933170593857536 |
|---|---|
| author | Satoshi Shimizu Miho Yamada Takahiro Katagiri Yoichi Sunagawa Yasufumi Katanasaka Yusuke Miyazaki Masafumi Funamoto Sari Nurmila Kana Shimizu Naohisa Ogo Akira Asai Koji Hasegawa Tatsuya Morimoto |
| author_facet | Satoshi Shimizu Miho Yamada Takahiro Katagiri Yoichi Sunagawa Yasufumi Katanasaka Yusuke Miyazaki Masafumi Funamoto Sari Nurmila Kana Shimizu Naohisa Ogo Akira Asai Koji Hasegawa Tatsuya Morimoto |
| author_sort | Satoshi Shimizu |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:39:36Z |
| format | Article |
| id | doaj.art-0a6ff42675f54a0b8898faa6555af0cc |
| institution | Directory Open Access Journal |
| issn | 1758-3756 1758-3764 |
| language | English |
| last_indexed | 2025-02-17T17:27:43Z |
| publishDate | 2021-12-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | European Cardiology Review |
| spelling | doaj.art-0a6ff42675f54a0b8898faa6555af0cc2024-12-14T16:03:20ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642021-12-011610.15420/ecr.2021.16.PO10Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening AssaySatoshi Shimizu0Miho Yamada1Takahiro Katagiri2Yoichi Sunagawa3Yasufumi Katanasaka4Yusuke Miyazaki5Masafumi Funamoto6Sari Nurmila7Kana Shimizu8Naohisa Ogo9Akira Asai10Koji Hasegawa11Tatsuya Morimoto12Division of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, Japan; Shizuoka General Hospital, Shizuoka, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, Japan; Shizuoka General Hospital, Shizuoka, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, Japan; Shizuoka General Hospital, Shizuoka, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, JapanCentre for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan;Centre for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan;Division of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, JapanDivision of Molecular Medicine, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, Japan; Shizuoka General Hospital, Shizuoka, Japanhttps://www.ecrjournal.com/articleindex/ecr.2021.16.PO10 |
| spellingShingle | Satoshi Shimizu Miho Yamada Takahiro Katagiri Yoichi Sunagawa Yasufumi Katanasaka Yusuke Miyazaki Masafumi Funamoto Sari Nurmila Kana Shimizu Naohisa Ogo Akira Asai Koji Hasegawa Tatsuya Morimoto Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay European Cardiology Review |
| title | Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay |
| title_full | Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay |
| title_fullStr | Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay |
| title_full_unstemmed | Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay |
| title_short | Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay |
| title_sort | discovery of novel small molecules for heart failure therapy using cultured cardiomyocyte by high throughput screening assay |
| url | https://www.ecrjournal.com/articleindex/ecr.2021.16.PO10 |
| work_keys_str_mv | AT satoshishimizu discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT mihoyamada discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT takahirokatagiri discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT yoichisunagawa discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT yasufumikatanasaka discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT yusukemiyazaki discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT masafumifunamoto discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT sarinurmila discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT kanashimizu discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT naohisaogo discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT akiraasai discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT kojihasegawa discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay AT tatsuyamorimoto discoveryofnovelsmallmoleculesforheartfailuretherapyusingculturedcardiomyocytebyhighthroughputscreeningassay |